Patients treated with L-asparaginase may present with hemorrhagic and thrombotic cerebrovascular events. This syndrome generally occurs after a few weeks of therapy and may occur after L-asparaginase therapy is completed. Compli cations appear to result from depletion of plasma proteins in volved in coagulation and fibrinolysis. Seizures are uncommon symptoms, and are always caused by cerebrovascular events. We report a case of seizure associated with L-asparaginase therapy but no evidence of hemorrhagic or thrombotic cerebro vascular events.
Goldberg DMEnzymes as agents for the treatment of disease. Clin Chim Acta1992;206(3):45.
10.
Weiss RB, Baker JR Jr. Hypersensitivity reactions from antineoplastic agents. Cancer Metastasis Rev1987;6(3):413.
11.
Weiss RB, Bruno S.Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Intern Med1981;94(1):66.
12.
Pritsa A., Choli-Papadopoulou T., Kyriakidis DAStudies on the primary structure of L-asparaginase from Thermus thermophilus . J Protein Chem1998;17(6):548.
13.
Feinberg WM , Swenson MRCerebrovascular complications of L-asparaginase therapy. Neurology1988;38(1):127.
14.
Shapiro WR, Young DFNeurological complications of antineoplastic therapy. Acta Neurol Scand1984;100(suppl):125.
15.
Priest JR, Ramsay NK, Bennett AJ, Krivit W., Edson JRThe effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr1982;100(6):990.
16.
Coleman CN, Picozzi VJ, Cox RS, et al. Treatment of lymphoblastic lymphoma in adults. J Clin Oncol1986;4:1628.
17.
Slater DE, Mertelsmann R., Koziner B., et al. Lymphoblastic lymphoma in adults. J Clin Oncol1986;4:57.
18.
Reiter A., Schrappe M., Parwaresch R., et al. Non-Hodgkin's lymphoma of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage—report of the Berlin-Frankfurt- Munster group. J Clin Oncol1995;13:359.
19.
Graham ML, Asselin BL, Herndon JE II, et al. Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplantation1998;21(9):879.
20.
Priest JR, Ramsay NK, Steinherz PG, et al. A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia. J Pediatr1992;100(6): 984.
21.
Cairo MS, Lazarus K., Gilmore RL, Baehner RLIntracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia. J Pediatr1980;97(5):829.
22.
Goulatia RK , Verma A., Mishra NK, Ahuja GKDisappearing CT lesions in epilepsy. Epilepsia1987;28(5):523.
Sethi PK, Kumar BR, Madan VS, Mohan V.Appearing and disappearing CT scan abnormalities and seizures. J Neurol Neurosurg Psychiatry1985;48(9):866.
25.
Gastaut H., Gastaut JLComputerized transverse axial tomography in epilepsy. Epilepsia1976;17(3):325.
26.
Nakakita K. , Tanaka S., Fuji C., Kohama A.Circulatory disturbance of deep cerebral veins in eclampsia. No To Shinkei1990;42(3):239.
27.
Ito Y., Niwa H., Ando T., Yasuda T., Yanagi T.Clinical and neuro-radiological studies of eclampsia-cerebral vasospasm and relation to the brain edema. Rinsho Shineigaku1995;35(4):358.
28.
Dillon W., Brant-Zawadzki M., Sherry RGTransient computer tomographic abnormalities after focal seizures. Am J Neuroradiol1984;5(1):107.
Wadia RS, Makhale CN, Kelkar AV, Grant KBFocal epilepsy in India with special reference to lesions showing ring or disc-like enhancement on contrast computed tomography. J Neurol Neurosurg Psychiatry1987;50(10):1298.
